DCBO (DCBO) Stock Price & Analysis
DCBO (DCBO) rose 2.00% to USD 19.37 as of July 25, 2026 at 04:24 UTC, according to Nexqual real-time market data.
DCBO last closed at USD 18.99; the session ranged USD 19.18–19.62 on volume of 46,044 shares. Market capitalization is $491.66M, with a 52-week range of USD 14.39–33.42 (NMS). Source: Nexqual, July 25, 2026 at 04:24 UTC.
Key Statistics (as of July 25, 2026 at 04:24 UTC)
| Price | USD 19.37 |
|---|---|
| Change | ▲ 2.00% (up) |
| Previous Close | USD 18.99 |
| Open | USD 19.19 |
| Day Range | USD 19.18 – 19.62 |
| 52-Week Range | USD 14.39 – 33.42 |
| Volume | 46,044 shares |
| Market Cap | $491.66M |
| Exchange | NMS |
Technical Analysis (DCBO)
Nexqual's technical model rates DCBO "STRONG BUY" based on 5 bullish and 0 bearish signals across 125 daily candles, as of July 25, 2026 at 04:24 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 56.73 (neutral) |
| vs SMA50 | Above (USD 17.98) |
| MACD | 0.4 (positive) |
Analyst Ratings (DCBO)
Wall Street analysts rate DCBO "Buy" based on 11 analysts, with a mean price target of USD 28.77 (range USD 22–38), per Nexqual as of July 25, 2026 at 04:24 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 11 |
| Mean Target | USD 28.77 |
| High Target | USD 38 |
| Low Target | USD 22 |
| Buy / Hold / Sell | 10 / 2 / 0 |
Earnings (DCBO)
| Next Earnings Date | 2026-08-07 |
|---|---|
| EPS Estimate | USD 0.3 |
| Revenue Estimate | $68.16M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 0.34 vs est 0.35 ▼ miss |
| 2025-12-31 | USD 0.45 vs est 0.36 ▲ beat |
| 2025-09-30 | USD 0.34 vs est 0.33 ▲ beat |
| 2025-06-30 | USD 0.29 vs est 0.22 ▲ beat |
Source: Nexqual, July 25, 2026 at 04:24 UTC.
Financials & Fundamentals (DCBO)
| Total Revenue | $251.01M |
|---|---|
| Revenue Growth (YoY) | +14.50% |
| Gross Margin | +79.67% |
| Operating Margin | -0.06% |
| Profit Margin | +13.71% |
| ROE | +132.85% |
| Current Ratio | 0.85 |
| Total Cash | $63.19M |
| Total Debt | $83.80M |
| Free Cash Flow | $43.06M |
Source: Nexqual, July 25, 2026 at 04:24 UTC.
Financial Health Score (DCBO)
Nexqual rates DCBO's overall financial health "Solid" across five dimensions, as of July 25, 2026 at 04:24 UTC.
| Growth | Solid — Revenue +12% YoY (annual) |
|---|---|
| Profitability | Solid — Gross margin 80%, operating -0% |
| Balance Sheet | Mixed — $63M cash vs $84M debt |
| Cash Flow | Strong — FCF $43M, 18% margin |
| Efficiency | Strong — ROE 133%, ROA 7.7% |
Ownership (DCBO)
| Insider Ownership | +63.70% |
|---|---|
| Institutional Ownership | +27.28% |
| Shares Outstanding | 25.38M |
| Float | 9.36M |
Source: Nexqual, July 25, 2026 at 04:24 UTC.
Leadership (DCBO)
DCBO is led by Alessio Artuffo (age 43), CEO, President & Director, per Nexqual as of July 25, 2026 at 04:24 UTC.
| CEO, President & Director | Alessio Artuffo (age 43) |
|---|---|
| Chief Financial Officer | Brandon Farber |
| Chief Marketing Officer | Kyle Lacy |
| Chief Revenue Officer | Mark Kosoglow |
| Chief Technology Officer | Riccardo LaRosa |
Major Backers & Investors (DCBO)
Notable institutional backers of DCBO include Beutel, Goodman & Company Ltd, Cat Rock Capital Management LP, Topline Capital Management, LLC, according to Nexqual as of July 25, 2026 at 04:24 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Beutel, Goodman & Company Ltd | 6.21% |
| Cat Rock Capital Management LP | 4.35% |
| Topline Capital Management, LLC | 3.5% |
| Arrowstreet Capital, Limited Partnership | 2.45% |
| Two Sigma Investments, LP | 1.09% |
| Essex Investment Management Co LLC | 0.69% |
| Louisbourg Investments Inc. | 0.64% |
| Renaissance Technologies | 0.43% |
Source: Nexqual, July 25, 2026 at 04:24 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| OM | Outset Medical, Inc. | USD 4.04 | ▼ 2.18% |
| LOB | Live Oak Bancshares, Inc. | USD 42.08 | ▲ 2.51% |
| WD | Walker & Dunlop, Inc | USD 48.2 | ▲ 0.98% |
| LSPD | Lightspeed Commerce Inc. Subord | USD 9.91 | ▲ 1.54% |
| DAVA | Endava plc | USD 2.66 | ▼ 2.92% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 04:24 UTC. This page is informational and not investment advice.